Table 1

Summary of the main results

5-day10-day
Subjects200197
Clinical status of 2–3 points at baseline53 (26)69 (35)
Clinical improvement at day 14129 (64)107 (54)
Any adverse events141 (70)145 (74)
Any serious adverse events42 (21)68 (35)

Data are presented as n or n (%). The reported numbers per group represent the number of patients per outcome. Information from [3].